Primary Sjögren's syndrome: Expression of NF-κB in minor salivary glands;Síndrome de Sjögren primario: Expresión del factor NF-κB en glándula salival menor

Reumatologia Clinica

Volumn 6, Issue 6, 2010, Pages 292-295

  Villalon, Liliana ^a   Mamani, Marta ^b   Romanini, Felix E ^b   Catalan Pellet, Antonio ^b   Berra, Alejandro ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Hospital Bernardino Rivadavia   (Argentina)

Author keywords

Expression of NF B in minor salivary glands; Primary Sj gren's syndrome

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LACRIMAL DUCT; LIP BIOPSY; LYMPHOCYTE; NEUTROPHIL; PROTEIN EXPRESSION; SALIVARY GLAND; SEROLOGY; SIALOADENITIS; SJOEGREN SYNDROME;

EID: 78149501256     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/j.reuma.2009.10.009     Document Type: Article

References (22)

1. Talal N. Sjogren's syndrome. Curr Opin Immunol 1989, 2:622-624.
2. Fox R.I. Sjogren's syndrome. Curr Opin Rheumatol 1995, 7:409-416.
3. Vitali C., Bombardieri S., Moutsopoulos H.M., Coll J., Gerli R., Hatron PY, et al. Assessment of the European classification criteria for Sjogren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjogren's Syndrome. Ann Rheum Dis 1996, 55:116-121.
4. Brun J.G., Madland T.M., Gjesdal C.B., Bertelsen L.T. Sjogren's syndrome in an out-patient clinic: classification of patients according to the preliminary European criteria and the proposed modified European criteria. Rheumatology (Oxford) 2002, 41:301-304.
5. Bloch K.J., Buchanan W.W., Wohl M.J., Bunim J.J. Sjoegren's Syndrome. A Clinical, Pathological, and Serological Study of Sixty-Two Cases. Medicine (Baltimore) 1965, 44:187-231.
6. Daniels T.E. Salivary histopathology in diagnosis of Sjogren's syndrome. Scand J Rheumatol Suppl 1986, 61:36-43.
7. Fox R.I. Sjogren's syndrome. Lancet 2005, 366:321-331.
8. Hansen A., Lipsky P.E., Dorner T. New concepts in the pathogenesis of Sjogren syndrome: many questions, fewer answers. Curr Opin Rheumatol 2003, 15:563-570.
9. Bacman S., Berra A., Sterin-Borda L., Borda E. Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjogren syndrome. Invest Ophthalmol Vis Sci 2001, 42:321-327.
10. Watanabe T., Tsuchida T., Kanda N., Mori K., Hayashi Y., Tamaki K. Anti-alpha-fodrin antibodies in Sjogren syndrome and lupus erythematosus. Arch Dermatol 1999, 135:535-539.
11. Sarkar F.H., Li Y., Wang Z., Kong D. NF-kappaB signaling pathway and its therapeutic implications in human diseases. Int Rev Immunol 2008, 27:293-319.
12. Brown K.D., Claudio E., Siebenlist U. The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis. Arthritis Res Ther 2008, 10:212.
13. Manoussakis M.N., Dimitriou I.D., Kapsogeorgou E.K. Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjogren's syndrome. Arthritis Rheum 1999, 42:229-239.
14. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos HM., Alexander EL., Carsons SE., et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558.
15. Chisholm D.M., Mason D.K. Labial salivary gland biopsy in Sjogren's disease. J Clin Pathol 1968, 21:656-660.
16. Hayden M.S., Ghosh S. Signaling to NF-kappaB. Genes Dev 2004, 18:2195-2224.
17. Perez P., Kwon Y.J., Alliende C., Leyton L., Aguilera S., Molina C., et al. Increased acinar damage of salivary glands of patients with Sjogren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios. Arthritis Rheum 2005, 52:2751-2760.
18. Lucas P.C., McAllister-Lucas L.M., Nunez G. NF-kappaB signaling in lymphocytes: a new cast of characters. J Cell Sci 2004, 117:31-39.
19. Ek M., Popovic K., Harris H.E., Naucler C.S., Wahren-Herlenius M. Increased extracellular levels of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in minor salivary glands of patients with Sjogren's syndrome. Arthritis Rheum 2006, 54:2289-2294.
20. Pullerits R., Jonsson I.M., Verdrengh M., Bokarewa M., Andersson U., Erlandsson-Harris H., et al. High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis. Arthritis Rheum 2003, 48:1693-1700.
21. Azuma M., Motegi K., Aota K., Hayashi Y., Sato M. Role of cytokines in the destruction of acinar structure in Sjogren's syndrome salivary glands. Lab Invest 1997, 77:269-280.
22. Martindale J.L., Holbrook N.J. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 2002, 192:1-15.